Get Your Personalized Supplement StackSupplement Stack Quiz

Proprietary Slimming Blend

Also known as: Phaseolus vulgaris L. Extract, White Kidney Bean Extract, Alpha-Amylase Inhibitors, Camellia sinensis Extract, Green Tea Extract, Catechins, Garcinia cambogia, (-)-Hydroxycitric Acid (HCA), Phaseolus vulgaris Extract Blend

Overview

Proprietary Slimming Blends typically combine ingredients aimed at blocking starch digestion, increasing thermogenesis, and inhibiting lipogenesis. A common component is *Phaseolus vulgaris* (white kidney bean extract), an alpha-amylase inhibitor. Other frequent ingredients include green tea extract (for catechins) and *Garcinia cambogia* (for (-)-hydroxycitric acid or HCA). Research support varies widely among these ingredients. *Phaseolus vulgaris* has the most robust evidence base, with multiple randomized controlled trials (RCTs) and meta-analyses suggesting modest weight and fat loss benefits. Green tea catechins have moderate evidence, while HCA has conflicting results. These blends are often marketed for weight management and appetite suppression.

Benefits

*Phaseolus vulgaris* demonstrates statistically significant, though clinically modest, weight loss. Meta-analysis of 11 RCTs (n=573) showed an average weight loss of 1.08 kg compared to placebo. Further studies (n=110) indicated a 3.26 kg reduction in body fat. These effects are most pronounced when combined with calorie-restricted diets. Green tea catechins may contribute to increased fat oxidation through thermogenesis. Some users report mild appetite suppression, although this effect is largely anecdotal. The efficacy of HCA remains controversial, with conflicting research findings regarding its impact on lipogenesis.

How it works

The blend works through multiple mechanisms. *Phaseolus vulgaris* inhibits alpha-amylase, reducing the digestion and absorption of dietary starch. This leads to fewer calories being absorbed from carbohydrates. Green tea catechins are believed to increase thermogenesis by enhancing norepinephrine-induced fat oxidation. HCA, found in *Garcinia cambogia*, is proposed to inhibit ATP-citrate lyase, an enzyme involved in lipogenesis, although this mechanism and its effectiveness are debated. These ingredients collectively aim to reduce calorie intake, increase energy expenditure, and decrease fat storage.

Side effects

Common side effects primarily involve gastrointestinal distress, including flatulence and diarrhea, reported in 5-15% of users. If the blend contains caffeine from sources like green tea extract, potential side effects include insomnia and tachycardia. These blends are contraindicated in pregnancy and breastfeeding due to insufficient safety data. Individuals with diabetes should exercise caution due to the potential risk of hypoglycemia. Drug interactions are possible, particularly with hypoglycemic agents. It's crucial to monitor blood glucose levels closely. Discontinue use if any adverse effects occur.

Dosage

Dosage recommendations vary depending on the specific ingredients and their concentrations within the blend. For *Phaseolus vulgaris*, effective dosages range from 445 to 3000 mg per day. Green tea extract is typically dosed to provide 250-500 mg of EGCG (epigallocatechin gallate) per day. HCA dosages range from 500-1500 mg per day, though its efficacy is less established. Starch blockers like *Phaseolus vulgaris* are best taken 30-60 minutes before meals. Due to limited long-term safety data, cycling these supplements for 8-12 weeks is advisable.

FAQs

How long does it take to see results?

Significant effects are typically observed after 12 or more weeks of consistent use, as demonstrated in RCTs. Results are more noticeable when combined with a calorie-restricted diet and regular exercise.

Does it work without diet and exercise?

The effects are modest when used alone. These blends are most effective as an adjunct to a calorie-restricted diet and exercise program, enhancing overall weight loss efforts.

Is it safe for long-term use?

There is limited data on the long-term safety of these blends beyond 6 months. It is advisable to cycle their use, taking breaks every 8-12 weeks, to minimize potential risks.

Are there any drug interactions?

Yes, potential interactions exist, especially with hypoglycemic agents. Individuals with diabetes should monitor their blood glucose levels closely. Consult with a healthcare professional before use, particularly if taking other medications.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/29677119/ – This systematic review and meta-analysis of 11 RCTs (n=573) found that *Phaseolus vulgaris* extract resulted in a statistically significant weight loss of 1.08 kg compared to placebo. Additionally, a separate analysis of body fat studies (n=110) showed a 3.26 kg reduction in body fat. The authors noted that some included studies were industry-funded, which could introduce bias.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5920428/ – This article discusses the potential mechanisms of action of *Phaseolus vulgaris* extract in promoting weight loss. It highlights the role of alpha-amylase inhibition in reducing starch digestion and absorption. The review also acknowledges the need for further research to fully elucidate the long-term effects and optimal usage of the extract.
https://www.bmj.com/content/369/bmj.m696 – This network meta-analysis compared 14 different diet patterns for weight loss. While it doesn't directly analyze specific supplements, it confirms the modest effects of using supplements as adjuncts to dietary interventions. The study emphasizes the importance of comprehensive lifestyle changes for sustainable weight management.
https://www.mdpi.com/1424-8247/14/11/1198 – This review highlights the risks associated with unregulated stimulants, such as ephedrine, in weight loss supplements. It underscores the need for safer, non-stimulant approaches to weight management. The authors advocate for the use of evidence-based ingredients with well-established safety profiles.
https://www.bmj.com/content/348/bmj.g2646 – This study examined the effectiveness of orlistat for weight management. While not directly related to the proprietary blend, it provides context on the challenges and limitations of pharmacological interventions for weight loss. The findings emphasize the importance of considering both efficacy and safety when evaluating weight loss strategies.